Dear Research Advocate, As anti-vaccine and anti-science rhetoric grows stronger and more toxic, it’s important not to shrink from stepping up to the threat it poses. As Dr. Peter Hotez observed in a powerful editorial last week (well worth the read, for many reasons), “Our scientific training did not include instructions for public engagement or navigating communications in a complex web of disinformation coming from multiple sources.” Dr. Hotez doesn’t let the science community off the hook on communicating though, saying: “we have the knowledge, intellectual heft, and humanitarian obligation” to develop effective ways to communicate science. He gives suggestions on how to meet the moment...
Dear Research Advocate, No one nation now leads the world in all aspects of science and engineering. This point was emphasized today by Julia Phillips, PhD, Chair of the NSB Committee on National Science and Engineering Policy, in a presentation on The State of U.S. Science and Engineering 2022 report. Dr. Phillips underscored how competitiveness going forward relies on making several strategic decisions, including investing much more in fostering underserved talent, and doing more to develop critical and emerging technologies. Catching my eye in the report itself were the lagging indicators on U.S. STEM education; a welcome new broader definition of the STEM workforce; and the dramatic...
Dear Research Advocate, We seldom open this letter highlighting one of our alliance meetings, but yesterday’s discussion about the Omicron variant of COVID-19 is a timely and important exception. We spoke with Amira Roess, PhD, MPH, Professor of Global Health and Epidemiology at George Mason University. She shared information in a way that makes it useful for kitchen table conversations as we all consider how to live and plan given Omicron. One thing that came through clearly in hearing from Dr. Roess is how important fast- and faster-paced research truly is. And the pace of research progress depends on investment. S&T Need & Opportunity: The Hill has published an op-ed I authored...
As the COVID-19 pandemic continued to challenge our nation and our world, the Research!America alliance promoted the need to fight present health threats and fund the medical research necessary to prepare for future health crises. The great strength of Research!America is our member organizations. We are grateful for your partnership, insights, and commitment to advocate for faster medical and public health progress. Throughout 2021, we advocated for statutory and regulatory policies that align with public and private sector-fueled R&D to advance progress against deadly and debilitating health issues. Successfully advocated for increased NIH, NSF, FDA, CDC, and AHRQ funding in pending...
Dear Research Advocate, It’s tempting to feel overwhelmed and/or helpless in the new year given headlines of disease, dysfunction, and discord. But even as Omicron exacts a toll and Congress struggles for consensus, it is critical to keep in mind that more unites than divides us. In the words of Dr. Francis Collins in an NPR interview last month, “Medical research should never be partisan... You want to find answers to medical problems that are threatening yourself or your family or your community or your constituents. We’re all in this together, wanting solutions to what ails us. To overcome health threats that affect us all, we must stay united in common cause to raise the priority of...

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln